BioCentury
ARTICLE | Clinical News

BioChaperone insulin combo: Phase I/II started

December 9, 2013 8:00 AM UTC

Adocia began a double-blind, crossover, German Phase I/II trial to compare a version of Lantus insulin glargine that uses Adocia's BioChaperone polymer technology in combination with Humalog insulin lispro vs. Humalog Mix insulin lispro/insulin lispro protamine in about 20 Type I diabetics. Adocia said the BioChaperone technology makes insulin glargine compatible with fast-acting insulin analogs and increases a protein's solubility, protects against enzyme degradation and extends the protein's action time. ...